← All organizations

Ovid Therapeutics Inc.

For profitWebsite ↗

Also known as: Ovid Therapeutics | Ovid Therapeutics Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Sep 9, 2019

Timeline

2010s

Jun 1, 2014
Ovid Therapeutics Inc.— Founded

Drugs by trial phase (2 distinct, 9 trials)

Phase 3 (1 own, 0 via acquisition)

gaboxadol

Phase 2 (1 own, 0 via acquisition)

Soticlestat

Indications

Studied for

Recent trials (11)

NCT04106557Lead sponsorPhase 3Sep 9, 2019
NCT03882918Lead sponsorPhase 2Feb 25, 2019
NCT03697161Study directorPhase 2Sep 17, 2018
NCT03697161Lead sponsorPhase 2Sep 17, 2018
NCT03694275CollaboratorPhase 2Sep 10, 2018
NCT03650452CollaboratorPhase 2Aug 8, 2018
NCT03635073CollaboratorPhase 2Jul 19, 2018
NCT03166215CollaboratorPhase 2Jun 13, 2017
NCT03109756Lead sponsorPhase 1Apr 3, 2017
NCT02996305Study directorPhase 2Jan 1, 2016
NCT02996305Lead sponsorPhase 2Jan 1, 2016

Details

Founded: New York, NY, US Jun 1, 2014
Last known activity: Sep 9, 2019